Clinical Trial Monitoring

Permanent URI for this collection

https://rscarchive.kuhes.ac.mw/handle/20.500.12988/216

Browse

Now showing 1 - 11 of 11

Restricted
CryptoDex: A randomized, double blind, placebo-controlled phase III trial of adjunctive dexamethasone in HIV infected adults with Cryptococcal Meningitis
(2012-10-04) Day, Jeremy
Restricted
Monitoring Plan for F75 Study
(2014-09-12) Mwakio, Stella
Restricted
A 12-month open-label randomized controlled trial to evaluate Sayana® Press suitability for at home subcutaneous self-injection procedures in adult women
(2014-10-21) Burke, Holly PhD, MPH
Restricted
Blended e learning, Training for treatment
(2015) Gebruiker, Lisa
Restricted
Antimalarial Dose Justification and Tolerability (ADJusT) Study of DHA-Piperaquine in the 5–24 kg Weight Band in Malawi Monitoring Plan
(2015) Ngwira, Atusaye
Restricted
Antimalarial Dose Justification and Tolerability (ADJusT) Study of DHA-Piperaquine in the 5–24 kg Weight Band in Malawi
(2015) Dianne J Terlouw
Restricted
Antimalarial Dose Justification and Tolerability (ADJusT) Study of DHA-Piperaquine in the 5–24 kg Weight Band in Malawi Technical Service Agreement
(2015) Ngwira, Atusaye
Restricted
A phase lll randomised, double blind, placebo-controlled trial of a reduced carbohydrate formulation of F75 therapeutic milk among children with severe acute malnutrition”, the “F75-trial
(2015-06-01) Ngwira, Atusaye
Restricted
A 12-month open-label randomized controlled trial to evaluate Sayana® Press suitability for at home subcutaneous self-injection procedures in adult women
(2015-06-23) Ngwira, Atusaye
Restricted
Antimalarial Dose Justification and Tolerability (ADJusT) Study of DHA-Piperaquine in the 5–24 kg Weight Band in Malawi
(2015-07-13) Dr Dianne J. Terlouw
Restricted
A non-randomized immunogenicity trial of World Health Organization (WHO) Pre-qualified Inactivated Influenza Vaccine (IIV) in children age 6 to 59 months residing in a malaria endemic area of Malawi
(2016-03-04) Ngwira, atusaye